The Body Against Itself, Bacteria Inside One’s Own Body Linked To Rheumatoid Arthritis And Other Autoimmune Diseases

Main Category: Arthritis / Rheumatology
Also Included In: Immune System / Vaccines;  Infectious Diseases / Bacteria / Viruses
Article Date: 09 Nov 2010 – 2:00 PST

email to a friend   printer friendly   opinions  
<!– rate article



Patient / Public:

4.75 (8 votes)

Healthcare Prof:

5 (2 votes)

Article Opinions: 1 posts

Researchers are using 21st-century technologies to investigate the century-old hypothesis that certain autoimmune diseases, including rheumatoid arthritis, are caused by bacteria living in the human body and will present their initial data this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

New Study Links Inflammation To Plaque Buildup In The Arteries Of People With Rheumatoid Arthritis

Main Category: Arthritis / Rheumatology
Also Included In: Cardiovascular / Cardiology;  Vascular
Article Date: 09 Nov 2010 – 2:00 PST

email to a friend   printer friendly   opinions  
<!– rate article



Patient / Public:

Healthcare Prof:

2.5 (2 votes)

Article Opinions: 0 posts

New data presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta show that systemic inflammation and rheumatoid arthritis disease activity may contribute to the progression of atherosclerosis in people with RA. The data also show that this progression may be modified favorably by TNF inhibitors and detrimentally by glucocorticoids.

New ACR/EULAR Classification Criteria May Identify Rheumatoid Arthritis In At-Risk People Prior To Clinical Presentation

Main Category: Arthritis / Rheumatology
Article Date: 09 Nov 2010 – 2:00 PST

email to a friend   printer friendly   opinions  
<!– rate article



Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts

Rheumatoid arthritis researchers are using the 2010 ACR/EULAR Rheumatoid Arthritis Classification Criteria in hopes of improving the ability to identify people with the RA even before they’re diagnosed with the disease in a clinical health care setting. They presented their findings this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

Frequency Of Foot Disorders Differs Between African Americans And Whites

Main Category: Arthritis / Rheumatology
Also Included In: Seniors / Aging
Article Date: 11 Nov 2010 – 0:00 PST

email to a friend   printer friendly   opinions  
<!– rate article



Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts

Common foot disorders such as flat feet, corns and bunions are more prevalent among African Americans than in whites, a new study by University of North Carolina at Chapel Hill researchers has found.

ChemoCentryx Reports Positive Phase I Results For CCX168, A Novel C5aR Antagonist, At The Annual American College Of Rheumatology Meeting (ACR)

Main Category: Arthritis / Rheumatology
Also Included In: Clinical Trials / Drug Trials;  Conferences;  Pharma Industry / Biotech Industry
Article Date: 11 Nov 2010 – 4:00 PST

email to a friend   printer friendly   opinions  
<!– rate article



Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts

Alpine Mountaineer And Alzheimer’s Advocate To Climb Highest Peak On Each Continent To Raise Awareness Of Growing Prevalence And Burden Of Alzheimer’s

Main Category: Arthritis / Rheumatology
Also Included In: Pharma Industry / Biotech Industry
Article Date: 11 Nov 2010 – 6:00 PST

email to a friend   printer friendly   opinions  
<!– rate article



Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts

Alpine mountaineer and Alzheimer’s disease advocate Alan Arnette will embark later this month to climb the 7 Summits, the highest peak on each continent. This ambitious year-long climbing campaign The 7 Summits Climb for Alzheimer’s: Memories are Everything aims to raise awareness of the growing Alzheimer’s prevalence in our aging population and the enormous financial and personal burden it places on people with the disease, their caregivers and society.

Combination Of Methotrexate And Prednisone Produces Remission In People With Newly-Developed Rheumatoid Arthritis And Undifferentiated Arthritis

Main Category: Arthritis / Rheumatology
Article Date: 09 Nov 2010 – 2:00 PST

email to a friend   printer friendly   opinions  
<!– rate article



Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts

People with newly-developed rheumatoid arthritis or undifferentiated arthritis may be able to achieve remission, with continued drug therapy, after four months of treatment with methotrexate and prednisone, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

New Data Show That Subcutaneous Injection Of An Investigational Formulation Of ORENCIA® Provided Similar Improvemnt Compared To Intraveous Therapy

Main Category: Arthritis / Rheumatology
Also Included In: Clinical Trials / Drug Trials;  Pharma Industry / Biotech Industry
Article Date: 10 Nov 2010 – 3:00 PST

email to a friend   printer friendly   opinions  
<!– rate article



Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts

BioCryst To Present New Data For BCX4208 Monotherapy At The 74th Annual American College Of Rheumatology (ACR) Scientific Meeting

Main Category: Gout
Also Included In: Arthritis / Rheumatology;  Conferences;  Pharma Industry / Biotech Industry
Article Date: 10 Nov 2010 – 3:00 PST

email to a friend   printer friendly   opinions  
<!– rate article



Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) announced the presentation of new data related to the efficacy and safety of BCX4208 for the treatment of gout at the 74th ACR Scientific Meeting being held in Atlanta, Georgia.

The data will be presented during a poster session scheduled for today, November 8, 2010 from 9:00-11:00 a.m. Eastern Time. The poster to be presented during the session is entitled:

Interleukin Genetics And The University Of North Carolina At Chapel Hill Announce Presentation Of Additional Clinical Study Findings On Osteoarthritis

Main Category: Arthritis / Rheumatology
Also Included In: Bones / Orthopedics;  Genetics;  Clinical Trials / Drug Trials
Article Date: 10 Nov 2010 – 4:00 PST

email to a friend   printer friendly   opinions  
<!– rate article



Patient / Public:

Healthcare Prof:

Article Opinions: 0 posts

Interleukin Genetics, Inc. (Pink Sheets: ILIU) and the Thurston Arthritis Research Center at the University of North Carolina at Chapel Hill announced additional findings from their previously reported 1,154-patient longitudinal study to evaluate the role of genetic factors in osteoarthritis (OA) progression. The new data, which will be presented for the first time at the American College of Rheumatology Annual Scientific Meeting in Atlanta, GA, indicates patients with radiographic signs of early knee osteoarthritis were genetically different from those without radiographic signs of the disease and progressed to moderate or severe OA at a much greater frequency.